Timothy Barreiro is a Respiratory physician affiliated with St. Elizabeth Youngstown Hospital. OpenAlex indexes 55 publications with 356 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1044 Belmont Ave
Youngstown, OH 445041006
Telephone
330-480-3258Registry record last updated 11 Oct 2016.
Clinical trials
- Intranasal TXA for Anterior Epistaxis in the Emergency Department
Sponsor: Mercy Health Ohio
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- United Therapeutics CorporationProgram year20251 payment
- Baxter HealthcareProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
77.1%Corticosteroid45.4%Trelegy Ellipta56%Breo Ellipta16%Breztri Aerosphere9%Symbicort8%Fluticasone Propionate5%Dulera3%Fluticasone Propionate Hfa2%Part D<11 patientsbeta2-Adrenergic Agonist20.9%Albuterol Sulfate Hfa81%Ventolin Hfa19%Part D≥46 patients+ 4 more classes in this area
Metabolism & gastrointestinal
8.4%Corticosteroid8.4%Prednisone100%Part D≥41 patientsNervous system
5.3%Benzodiazepine1.3%Alprazolam100%Part D<11 patientsNonsteroidal Anti-inflammatory Drug1.2%Ibuprofen100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Fasting Duration, Not Timing of Last GLP-1 Dose, Predicts Aspiration Risk Indicators: A Prospective Point-of-Care Gastric Ultrasound Study
Digestive Diseases and Sciences
2025 - When the Heart Defies the Poison: Normocardia Following Propranolol Overdose
American Journal of Respiratory and Critical Care Medicine
2025 - Evaluating lung cancer screening using low dose computed tomography (LDCT) scan in a community hospital: A retrospective study.
Journal of Clinical Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Andrea Shaer, MD
St. Elizabeth Youngstown Hospital
Hilmer Negrete, MD
St. Elizabeth Youngstown Hospital
Chander Kohli, MD
St. Elizabeth Youngstown Hospital
Nathaniel Doe, MD
St. Elizabeth Youngstown Hospital
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”